Drug profile · INN
burosumab-twza
CRYSVITA
- US status
- approved
- Patents linked
- 0
- News articles
- 0
Quick answer
burosumab-twza (CRYSVITA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
Key facts
INN burosumab-twza
Brand CRYSVITA
Route INJECTION
Formulation INJECTABLE
Frequently asked questions
What is burosumab-twza?
burosumab-twza (CRYSVITA) is an FDA-listed pharmaceutical active ingredient. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for burosumab-twza?
CRYSVITA is a marketed brand name for burosumab-twza. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of burosumab-twza?
burosumab-twza has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.